vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Commercial Vehicle Group, Inc. (CVGI). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $154.8M, roughly 1.8× Commercial Vehicle Group, Inc.). On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -5.2%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -10.8%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...

ACAD vs CVGI — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.8× larger
ACAD
$284.0M
$154.8M
CVGI
Growing faster (revenue YoY)
ACAD
ACAD
+14.6% gap
ACAD
9.4%
-5.2%
CVGI
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
-10.8%
CVGI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
CVGI
CVGI
Revenue
$284.0M
$154.8M
Net Profit
$273.6M
Gross Margin
90.8%
9.7%
Operating Margin
6.1%
-1.2%
Net Margin
96.3%
Revenue YoY
9.4%
-5.2%
Net Profit YoY
90.3%
EPS (diluted)
$1.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
CVGI
CVGI
Q4 25
$284.0M
$154.8M
Q3 25
$278.6M
$152.5M
Q2 25
$264.6M
$172.0M
Q1 25
$244.3M
$169.8M
Q4 24
$259.6M
$163.3M
Q3 24
$250.4M
$171.8M
Q2 24
$242.0M
$193.7M
Q1 24
$205.8M
$194.6M
Net Profit
ACAD
ACAD
CVGI
CVGI
Q4 25
$273.6M
Q3 25
$71.8M
$-7.1M
Q2 25
$26.7M
$-4.8M
Q1 25
$19.0M
$-4.3M
Q4 24
$143.7M
Q3 24
$32.8M
$9.5M
Q2 24
$33.4M
$-1.6M
Q1 24
$16.6M
$2.9M
Gross Margin
ACAD
ACAD
CVGI
CVGI
Q4 25
90.8%
9.7%
Q3 25
92.2%
10.5%
Q2 25
92.2%
11.4%
Q1 25
91.7%
10.5%
Q4 24
91.6%
8.0%
Q3 24
92.5%
9.6%
Q2 24
92.5%
10.6%
Q1 24
88.8%
11.9%
Operating Margin
ACAD
ACAD
CVGI
CVGI
Q4 25
6.1%
-1.2%
Q3 25
12.8%
-0.7%
Q2 25
12.2%
0.5%
Q1 25
7.9%
0.8%
Q4 24
59.1%
-3.2%
Q3 24
12.6%
-0.6%
Q2 24
12.6%
0.5%
Q1 24
7.4%
2.3%
Net Margin
ACAD
ACAD
CVGI
CVGI
Q4 25
96.3%
Q3 25
25.8%
-4.6%
Q2 25
10.1%
-2.8%
Q1 25
7.8%
-2.5%
Q4 24
55.4%
Q3 24
13.1%
5.5%
Q2 24
13.8%
-0.8%
Q1 24
8.0%
1.5%
EPS (diluted)
ACAD
ACAD
CVGI
CVGI
Q4 25
$1.61
Q3 25
$0.42
Q2 25
$0.16
Q1 25
$0.11
Q4 24
$0.86
Q3 24
$0.20
Q2 24
$0.20
$-0.05
Q1 24
$0.10
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
CVGI
CVGI
Cash + ST InvestmentsLiquidity on hand
$177.7M
Total DebtLower is stronger
$104.9M
Stockholders' EquityBook value
$1.2B
$133.4M
Total Assets
$1.6B
$391.7M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
CVGI
CVGI
Q4 25
$177.7M
Q3 25
$258.0M
Q2 25
$253.6M
Q1 25
$217.7M
Q4 24
$319.6M
Q3 24
$155.1M
Q2 24
$177.1M
Q1 24
$204.7M
Total Debt
ACAD
ACAD
CVGI
CVGI
Q4 25
$104.9M
Q3 25
$108.2M
Q2 25
$118.2M
Q1 25
$117.4M
Q4 24
$135.5M
Q3 24
$128.8M
Q2 24
$142.0M
Q1 24
$155.7M
Stockholders' Equity
ACAD
ACAD
CVGI
CVGI
Q4 25
$1.2B
$133.4M
Q3 25
$917.3M
$136.5M
Q2 25
$822.4M
$142.6M
Q1 25
$765.2M
$136.7M
Q4 24
$732.8M
$135.6M
Q3 24
$577.2M
$179.3M
Q2 24
$516.7M
$169.6M
Q1 24
$464.0M
$175.5M
Total Assets
ACAD
ACAD
CVGI
CVGI
Q4 25
$1.6B
$391.7M
Q3 25
$1.3B
$400.3M
Q2 25
$1.2B
$429.8M
Q1 25
$1.1B
$419.8M
Q4 24
$1.2B
$424.6M
Q3 24
$976.9M
$495.3M
Q2 24
$914.1M
$503.2M
Q1 24
$855.1M
$509.2M
Debt / Equity
ACAD
ACAD
CVGI
CVGI
Q4 25
0.79×
Q3 25
0.79×
Q2 25
0.83×
Q1 25
0.86×
Q4 24
1.00×
Q3 24
0.72×
Q2 24
0.84×
Q1 24
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
CVGI
CVGI
Operating Cash FlowLast quarter
$-48.7M
$12.3M
Free Cash FlowOCF − Capex
$8.7M
FCF MarginFCF / Revenue
5.6%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
-0.18×
TTM Free Cash FlowTrailing 4 quarters
$34.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
CVGI
CVGI
Q4 25
$-48.7M
$12.3M
Q3 25
$74.3M
$-1.7M
Q2 25
$64.0M
$18.9M
Q1 25
$20.3M
$15.2M
Q4 24
$40.4M
$-26.6M
Q3 24
$63.2M
$-17.1M
Q2 24
$25.0M
$12.6M
Q1 24
$29.1M
$-2.4M
Free Cash Flow
ACAD
ACAD
CVGI
CVGI
Q4 25
$8.7M
Q3 25
$73.9M
$-3.5M
Q2 25
$17.4M
Q1 25
$11.4M
Q4 24
$-30.6M
Q3 24
$63.2M
$-20.3M
Q2 24
$6.4M
Q1 24
$-7.4M
FCF Margin
ACAD
ACAD
CVGI
CVGI
Q4 25
5.6%
Q3 25
26.5%
-2.3%
Q2 25
10.1%
Q1 25
6.7%
Q4 24
-18.7%
Q3 24
25.2%
-11.8%
Q2 24
3.3%
Q1 24
-3.8%
Capex Intensity
ACAD
ACAD
CVGI
CVGI
Q4 25
2.3%
Q3 25
0.1%
1.2%
Q2 25
0.9%
Q1 25
2.2%
Q4 24
2.4%
Q3 24
0.0%
1.9%
Q2 24
3.2%
Q1 24
2.6%
Cash Conversion
ACAD
ACAD
CVGI
CVGI
Q4 25
-0.18×
Q3 25
1.03×
Q2 25
2.40×
Q1 25
1.07×
Q4 24
0.28×
Q3 24
1.93×
-1.79×
Q2 24
0.75×
Q1 24
1.76×
-0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

CVGI
CVGI

Global Seating$70.7M46%
Global Electrical Systems$49.7M32%
Trim Systems And Components$34.4M22%

Related Comparisons